Ultragenyx Pharmaceutical (RARE) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Ultragenyx Pharmaceutical (RARE) over the last 10 years, with Q3 2025 value amounting to -$1.0 million.
- Ultragenyx Pharmaceutical's Non Operating Income fell 13389.67% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 19916.96%. This contributed to the annual value of -$4.0 million for FY2024, which is 107596.44% down from last year.
- Per Ultragenyx Pharmaceutical's latest filing, its Non Operating Income stood at -$1.0 million for Q3 2025, which was down 13389.67% from $2.1 million recorded in Q2 2025.
- In the past 5 years, Ultragenyx Pharmaceutical's Non Operating Income registered a high of $3.1 million during Q3 2024, and its lowest value of -$3.6 million during Q4 2024.
- In the last 5 years, Ultragenyx Pharmaceutical's Non Operating Income had a median value of -$415000.0 in 2021 and averaged -$295736.8.
- In the last 5 years, Ultragenyx Pharmaceutical's Non Operating Income crashed by 128805.97% in 2022 and then skyrocketed by 103500.0% in 2023.
- Ultragenyx Pharmaceutical's Non Operating Income (Quarter) stood at -$410000.0 in 2021, then surged by 143.9% to $180000.0 in 2022, then surged by 1035.0% to $2.0 million in 2023, then plummeted by 276.51% to -$3.6 million in 2024, then skyrocketed by 71.08% to -$1.0 million in 2025.
- Its last three reported values are -$1.0 million in Q3 2025, $2.1 million for Q2 2025, and $837000.0 during Q1 2025.